Anula Jayasuriya

Insider Reports History

Location: 5150 El Camino Real, Suite #A 32, Los Altos, CA
Signature: /s/ Jonathan Wolin, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anula Jayasuriya:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Lineage Cell Therapeutics, Inc.	Director	Common Shares, no par value	10K	$10.9K	$1.09	Dec 29, 2023	Direct
Lineage Cell Therapeutics, Inc.	Director	Stock Option (Right to Buy)	75K			Jul 1, 2024	Direct
Jaguar Health, Inc.	Director	Stock option (right to buy)	21K			Oct 8, 2024	Direct

Showing 1 to 3 of 3 entries

Insider Reports Filed by Anula Jayasuriya

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
JAGX	Jaguar Health, Inc.	Oct 8, 2024	1	$0	4	Oct 10, 2024	Director
LCTX	Lineage Cell Therapeutics, Inc.	Jul 1, 2024	1	$0	4	Jul 3, 2024	Director
LCTX	Lineage Cell Therapeutics, Inc.	Dec 29, 2023	1	$10.9K	4	Jan 2, 2024	Director
JAGX	Jaguar Health, Inc.	Jul 1, 2023	3	$0	4	Aug 14, 2023	Director
LCTX	Lineage Cell Therapeutics, Inc.	Jul 1, 2023	1	$0	4	Jul 3, 2023	Director
JAGX	Jaguar Health, Inc.	Apr 6, 2023	1	$0	4	Apr 6, 2023	Director
LCTX	Lineage Cell Therapeutics, Inc.	Jul 1, 2022	1	$0	4	Jul 6, 2022	Director
JAGX	Jaguar Health, Inc.	Jul 1, 2022	0	$0	3	Jul 5, 2022	Director
LCTX	Lineage Cell Therapeutics, Inc.	Jul 1, 2021	1	$0	4	Jul 1, 2021	Director